During this year’s CPhI Worldwide congress in Frankfurt, the India Brand Equity Foundation (IBEF) and the Pharmaceuticals Export Promotion Council (Pharmexcil) provided an update on India’s generics market, confirming it accounts for 98% of the marketplace.
India generics
The data presented showed that the country accounts for over 20% of global production of generics with a value that currently exceeds $12 billion. Pharmexcil also forecasted that generic exports are now growing at around 22% per year, covering more than 60,000 brands and 60 therapeutic classes.